GlassScriptPhysician profile
Abim Sharma
NPI 1356786966
$23,070.06
in general payments reported to CMS, 2019-2025
17 companies · $4,782 in 2025
The $4,782 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,268 · 2022: $6,052 · 2023: $4,364 · 2024: $4,605 · 2025: $4,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $12.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,738.05 |
| Education | $12.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,723.14 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $4,969.54 | 2021-2025 | General - Therapies, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $4,162.73 | 2021-2025 | Aveir, Amplatzer Amulet, Jot Dx |
| Biotronik INC. | $632.43 | 2021-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Edora 8 Dr-T |
| Biosense Webster, INC. | $589.70 | 2021-2025 | Nuvision Ice Catheter, Carto 3, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $324.75 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $170.07 | 2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $167.09 | 2022-2024 | Xarelto |
| Cardiva Medical, INC. | $103.26 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $52.98 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| E.R. Squibb & Sons, L.L.C. | $36.25 | 2021 | |
| Chiesi USA, INC. | $36.06 | 2022-2023 | Cleviprex, Kengreal |
| Pfizer INC. | $24.94 | 2024 | |
| Teleflex LLC | $23.40 | 2025 | Chocolate |
| Bayer Healthcare Pharmaceuticals INC. | $19.39 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $17.79 | 2024 | |
| Merck Sharp & Dohme LLC | $16.54 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abim Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.